Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Winer

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Expert Opinion on Investigational Drugs|November 25, 2011
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesJorge J Castillo, Michael Furman, Eric S Winer
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
CD30-positive EBV-associated diffuse large B-cell lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemiaAhmad Alduaij, Diana O Treaba, Eric S Winer
Leukemia & Lymphoma|May 10, 2015
Primary mediastinal large B-cell lymphoma in pregnancyStephen Fiascone, Ilina Datkhaeva, Eric S Winer, et al.
Oncology (Williston Park, N.Y.)|June 7, 2005
GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDSEric S Winer, Kenneth B Miller, Geoffrey W Chan
American Journal of Hematology|November 26, 2013
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Leukemia Research|May 20, 2014
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphomaAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer Causes & Control : CCC|June 10, 2015
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data BaseAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer|August 6, 2013
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Expert Opinion on Investigational Drugs|February 4, 2012
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignanciesEric S Winer, Randall R Ingham, Jorge J Castillo
Wiener Klinische Wochenschrift|March 23, 2013
Chemotherapy of vulvar cancer: a reviewGunter Deppe, Ismail Mert, Jimmy Belotte, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Expert Opinion on Investigational Drugs|November 25, 2011
CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignanciesJorge J Castillo, Michael Furman, Eric S Winer
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
CD30-positive EBV-associated diffuse large B-cell lymphoma occurring after immunosuppressive therapy for T-cell prolymphocytic leukemiaAhmad Alduaij, Diana O Treaba, Eric S Winer
Leukemia & Lymphoma|May 10, 2015
Primary mediastinal large B-cell lymphoma in pregnancyStephen Fiascone, Ilina Datkhaeva, Eric S Winer, et al.
Oncology (Williston Park, N.Y.)|June 7, 2005
GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDSEric S Winer, Kenneth B Miller, Geoffrey W Chan
American Journal of Hematology|November 26, 2013
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Leukemia Research|May 20, 2014
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphomaAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer Causes & Control : CCC|June 10, 2015
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data BaseAdam J Olszewski, Eric S Winer, Jorge J Castillo
Cancer|August 6, 2013
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Expert Opinion on Investigational Drugs|February 4, 2012
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignanciesEric S Winer, Randall R Ingham, Jorge J Castillo
Wiener Klinische Wochenschrift|March 23, 2013
Chemotherapy of vulvar cancer: a reviewGunter Deppe, Ismail Mert, Jimmy Belotte, et al.
Pageof 12